European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations meeting with all eligible organisations

• Date:
  Friday, 30 November 2012, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This meeting discusses issues in relation to the general involvement of patients' organisations in the Agency's activities, giving particular focus to the new policy on conflicts of interests, funding of organisations, training strategy, involvement in benefit-risk evaluations and the new pharmacovigilance legislation, as well as presentations concerning the Innovative Medicines Initiative and the European Patients' Academy on Therapeutic Innovation.

Documents

Agenda - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations meeting with all eligible organisations

AdoptedReference Number: EMA/658954/2012

List of participants - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations plenary meeting with all eligible organisations: 30 November 2012 meeting

Reference Number: EMA/725895/2012

Minutes of European Medicines Agency Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations meeting with all eligible organisations: 30 November 2012 meeting

AdoptedReference Number: EMA/774808/2012

Experience following implementation of revised policy on handling of conflicts of interests - Guidance on completion of electronic declaration of interests (S. Kennedy)

Handling conflicts of interest for patients’ and consumers’ organisations (J. Garcia)

European Medicines Agency training strategy for patients and consumers (N. Bere)

Involvement of patients in CHMP benefit-risk (J. Garcia)

Involvement of patients in PRAC benefit-risk (J. M. Raine)

Boosting drug development through public-private partnerships: The Innovative Medicines Initiative model (H. Laverty)

European Patients’ Academy on Therapeutic Innovation (J. Geissler)